Valion Bio estimates Q3 net loss of about $16.2M
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Valion Bio, Inc. (VBIO) expects to file its Form 10-Q for the quarter ended September 30, 2026 within the five-calendar-day extension period provided by Rule 12b-25, after needing additional time to compile, review and finalize its financial statements and related disclosures.
Based on preliminary information, Valion estimates net losses of approximately $16.2 million for the three months and $29.5 million for the nine months ended September 30, 2026, versus approximately $2.6 million and $6.0 million in the comparable 2025 periods. Valion attributes the increase primarily to write-downs for long-lived asset and goodwill impairment, higher research and development and selling, general and administrative expenses, and interest expense. The estimates remain subject to review and finalization.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Major pointQ3 net loss: approximately $16.2 million, versus $2.6 million in 2025.
Key Figures
Key Terms
impairment of long-lived assets and goodwill financial
Rule 12b-25 regulatory
contract development and manufacturing organization technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What net loss does VBIO expect for the third quarter and first nine months of 2026?
Why is VBIO's Form 10-Q late?
AI-generated analysis. How Rhea-AI works. Not financial advice.